Sustained Release Ocular Drug Delivery Systems - Global Market Insights and Sales Trends 2024

Sustained Release Ocular Drug Delivery Systems - Global Market Insights and Sales Trends 2024

Table of Contents
1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Sustained Release Ocular Drug Delivery Systems Product Overview
1.2 Sustained Release Ocular Drug Delivery Systems Market Segment by Type
1.2.1 Liposome
1.2.2 Microcapsules/Nanocapsules
1.2.3 Microspheres/Nanosptheres
1.2.4 Implants
1.3 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2018-2023)
2 Global Sustained Release Ocular Drug Delivery Systems Market Competition by Company
2.1 Global Top Players by Sustained Release Ocular Drug Delivery Systems Sales (2018-2023)
2.2 Global Top Players by Sustained Release Ocular Drug Delivery Systems Revenue (2018-2023)
2.3 Global Top Players by Sustained Release Ocular Drug Delivery Systems Price (2018-2023)
2.4 Global Top Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sustained Release Ocular Drug Delivery Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
2.8 Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sustained Release Ocular Drug Delivery Systems Status and Outlook by Region
3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size by Region
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2018-2023)
3.2.3 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Region
3.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2024-2029)
3.3.3 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sustained Release Ocular Drug Delivery Systems by Application
4.1 Sustained Release Ocular Drug Delivery Systems Market Segment by Application
4.1.1 Cataract
4.1.2 Glaucoma
4.1.3 Corneal Transplantation
4.1.4 Others
4.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2018-2023)
5 North America Sustained Release Ocular Drug Delivery Systems by Country
5.1 North America Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
5.1.1 North America Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2023)
5.2 North America Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
5.2.1 North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2029)
6 Europe Sustained Release Ocular Drug Delivery Systems by Country
6.1 Europe Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
6.1.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2023)
6.2 Europe Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
6.2.1 Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Sustained Release Ocular Drug Delivery Systems by Region
7.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Historic Market Size by Region
7.1.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2024-2029)
8 Latin America Sustained Release Ocular Drug Delivery Systems by Country
8.1 Latin America Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
8.1.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2023)
8.2 Latin America Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
8.2.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Sustained Release Ocular Drug Delivery Systems by Country
9.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Historic Market Size by Country
9.1.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 pSivida
10.1.1 pSivida Company Information
10.1.2 pSivida Introduction and Business Overview
10.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
10.1.5 pSivida Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Products Offered
10.2.5 Allergan Recent Development
10.3 Icon Bioscience
10.3.1 Icon Bioscience Company Information
10.3.2 Icon Bioscience Introduction and Business Overview
10.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Products Offered
10.3.5 Icon Bioscience Recent Development
10.4 Ocular Therapeutix
10.4.1 Ocular Therapeutix Company Information
10.4.2 Ocular Therapeutix Introduction and Business Overview
10.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Products Offered
10.4.5 Ocular Therapeutix Recent Development
10.5 Neurotech Pharmaceuticals
10.5.1 Neurotech Pharmaceuticals Company Information
10.5.2 Neurotech Pharmaceuticals Introduction and Business Overview
10.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
10.5.5 Neurotech Pharmaceuticals Recent Development
10.6 Santen Pharmaceutical
10.6.1 Santen Pharmaceutical Company Information
10.6.2 Santen Pharmaceutical Introduction and Business Overview
10.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Products Offered
10.6.5 Santen Pharmaceutical Recent Development
10.7 Aciont Inc.
10.7.1 Aciont Inc. Company Information
10.7.2 Aciont Inc. Introduction and Business Overview
10.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Products Offered
10.7.5 Aciont Inc. Recent Development
10.8 Envisia Therapeutics
10.8.1 Envisia Therapeutics Company Information
10.8.2 Envisia Therapeutics Introduction and Business Overview
10.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Products Offered
10.8.5 Envisia Therapeutics Recent Development
10.9 GrayBug
10.9.1 GrayBug Company Information
10.9.2 GrayBug Introduction and Business Overview
10.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Products Offered
10.9.5 GrayBug Recent Development
10.10 Innocore Pharmaceuticals
10.10.1 Innocore Pharmaceuticals Company Information
10.10.2 Innocore Pharmaceuticals Introduction and Business Overview
10.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
10.10.5 Innocore Pharmaceuticals Recent Development
10.11 OHR Pharmaceuticals
10.11.1 OHR Pharmaceuticals Company Information
10.11.2 OHR Pharmaceuticals Introduction and Business Overview
10.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
10.11.5 OHR Pharmaceuticals Recent Development
10.12 PolyActiva
10.12.1 PolyActiva Company Information
10.12.2 PolyActiva Introduction and Business Overview
10.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Products Offered
10.12.5 PolyActiva Recent Development
10.13 TheraKine
10.13.1 TheraKine Company Information
10.13.2 TheraKine Introduction and Business Overview
10.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Products Offered
10.13.5 TheraKine Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
11.4 Sustained Release Ocular Drug Delivery Systems Market Dynamics
11.4.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
11.4.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
11.4.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
11.4.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sustained Release Ocular Drug Delivery Systems Distributors
12.3 Sustained Release Ocular Drug Delivery Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Liposome
Table 2. Major Company of Microcapsules/Nanocapsules
Table 3. Major Company of Microspheres/Nanosptheres
Table 4. Major Company of Implants
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (K Pcs)
Table 7. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (US& Million)
Table 9. Global Sustained Release Ocular Drug Delivery Systems Market Share in Value by Type (2018-2023)
Table 10. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2018-2023) & (USD/Pcs)
Table 11. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2024-2029) & (K Pcs)
Table 12. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type (2024-2029)
Table 15. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2024-2029) & (USD/Pcs)
Table 16. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (K Pcs)
Table 17. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2023)
Table 19. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2023)
Table 21. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2023)
Table 23. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2018-2023)
Table 25. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Sustained Release Ocular Drug Delivery Systems Sales by Company (2018-2023) & (K Pcs)
Table 27. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Company (2018-2023)
Table 28. Global Sustained Release Ocular Drug Delivery Systems Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Company (2018-2023)
Table 30. Global Market Sustained Release Ocular Drug Delivery Systems Price by Company (2018-2023) & (USD/Pcs)
Table 31. Global Sustained Release Ocular Drug Delivery Systems Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2022)
Table 34. Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
Table 35. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Sustained Release Ocular Drug Delivery Systems Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2023) & (K Pcs)
Table 39. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2018-2023)
Table 42. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 43. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2029) & (K Pcs)
Table 44. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2024-2029)
Table 47. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
Table 48. Global Sustained Release Ocular Drug Delivery Systems Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (K Pcs)
Table 50. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2018-2023)
Table 53. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2018-2023) & (USD/Pcs)
Table 54. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2024-2029) & (K Pcs)
Table 55. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2024-2029)
Table 58. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2024-2029) & (USD/Pcs)
Table 59. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) (K Pcs)
Table 60. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) (K Pcs)
Table 62. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) (K Pcs)
Table 64. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) (K Pcs)
Table 66. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) (K Pcs)
Table 68. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (K Pcs)
Table 70. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2023)
Table 73. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (K Pcs)
Table 74. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (K Pcs)
Table 78. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (K Pcs)
Table 82. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2023) & (K Pcs)
Table 86. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2029) & (K Pcs)
Table 90. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (K Pcs)
Table 94. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (K Pcs)
Table 98. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (K Pcs)
Table 102. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (K Pcs)
Table 106. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Country (2024-2029)
Table 109. pSivida Company Information
Table 110. pSivida Introduction and Business Overview
Table 111. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 113. pSivida Recent Development
Table 114. Allergan Company Information
Table 115. Allergan Introduction and Business Overview
Table 116. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. Allergan Sustained Release Ocular Drug Delivery Systems Product
Table 118. Allergan Recent Development
Table 119. Icon Bioscience Company Information
Table 120. Icon Bioscience Introduction and Business Overview
Table 121. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
Table 123. Icon Bioscience Recent Development
Table 124. Ocular Therapeutix Company Information
Table 125. Ocular Therapeutix Introduction and Business Overview
Table 126. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
Table 128. Ocular Therapeutix Recent Development
Table 129. Neurotech Pharmaceuticals Company Information
Table 130. Neurotech Pharmaceuticals Introduction and Business Overview
Table 131. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 133. Neurotech Pharmaceuticals Recent Development
Table 134. Santen Pharmaceutical Company Information
Table 135. Santen Pharmaceutical Introduction and Business Overview
Table 136. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 137. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
Table 138. Santen Pharmaceutical Recent Development
Table 139. Aciont Inc. Company Information
Table 140. Aciont Inc. Introduction and Business Overview
Table 141. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
Table 143. Aciont Inc. Recent Development
Table 144. Envisia Therapeutics Company Information
Table 145. Envisia Therapeutics Introduction and Business Overview
Table 146. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
Table 148. Envisia Therapeutics Recent Development
Table 149. GrayBug Company Information
Table 150. GrayBug Introduction and Business Overview
Table 151. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 152. GrayBug Sustained Release Ocular Drug Delivery Systems Product
Table 153. GrayBug Recent Development
Table 154. Innocore Pharmaceuticals Company Information
Table 155. Innocore Pharmaceuticals Introduction and Business Overview
Table 156. Innocore Pharmaceuticals

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs